Financial Statements — ORMP
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 15.25 | 13.20 | 52.18 | 15.80 | 74.52 | 42.10 | 84.75 | 18.58 | 5.47 | 6.77 | 24.10 | 33.20 | 29.89 | 31.88 | 57.41 | 33.81 | 14.93 |
| Short-term Investments | 0.85 | 4.97 | 4.96 | 1.75 | 3.70 | 0.65 | 2.35 | 2.03 | 0.05 | 0.94 | 2.27 | 5.23 | 6.63 | 7.28 | 7.21 | 7.75 | 8.82 |
| Total Current Assets | 53.41 | 68.15 | 136.12 | 99.03 | 131.48 | 142.77 | 153.27 | 177.10 | 175.71 | 150.97 | 155.16 | 160.17 | 134.87 | 143.56 | 72.23 | 147.94 | 36.02 |
| Property, Plant & Equipment | 0.53 | 0.56 | 0.61 | 0.65 | 0.67 | 0.72 | 0.77 | 0.82 | 0.92 | 0.95 | 0.98 | 0.54 | 0.43 | 0.42 | 0.39 | 0.39 | 0.41 |
| Total Non-current Assets | 316.24 | 200.70 | 84.38 | 62.66 | 16.06 | 22.31 | 30.95 | 26.56 | 55.19 | 5.34 | 4.62 | 4.26 | 27.42 | 28.66 | 8.26 | 29.88 | 4.95 |
| Total Assets | 369.64 | 268.85 | 220.49 | 161.68 | 147.54 | 165.08 | 184.22 | 203.65 | 230.89 | 156.31 | 159.78 | 164.44 | 162.29 | 172.22 | 80.49 | 177.82 | 40.97 |
| Accounts Payable | 8.51 | 8.52 | 4.86 | 2.16 | 5.28 | 5.00 | 3.48 | 1.27 | 2.56 | 0.83 | 4.06 | 4.21 | 3.48 | 3.31 | 2.86 | 4.54 | 2.81 |
| Short-term Debt | -- | -- | -- | -- | -- | -- | -- | 32.03 | 75.36 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.73 | 10.56 | 6.12 | 3.69 | 5.49 | 5.27 | 3.73 | 33.56 | 78.18 | 1.07 | 4.97 | 6.53 | 6.42 | 6.32 | 5.75 | 7.37 | 5.74 |
| Long-term Debt | -- | -- | -- | -- | -- | -- | -- | -- | 74.55 | -- | -- | 5.23 | 7.31 | 9.23 | -- | 11.62 | -- |
| Total Non-current Liabilities | 41.44 | 20.01 | 12.04 | 4.41 | 2.15 | 4.29 | 4.34 | 4.38 | 4.49 | 4.59 | 4.66 | 4.76 | 2.84 | 3.68 | 5.55 | 3.84 | 7.02 |
| Total Liabilities* | -- | -- | 17.21 | 7.16 | 6.73 | 8.64 | 7.16 | 37.01 | 81.76 | 4.77 | 8.81 | 10.63 | 8.59 | 9.88 | 12.37 | 11.37 | 12.76 |
| Retained Earnings | (6.96) | (85.12) | (122.57) | (170.97) | (184.26) | (166.43) | (146.81) | (156.02) | (170.89) | (167.67) | (166.48) | (154.54) | (147.48) | (136.94) | (108.00) | (126.52) | (98.18) |
| Total Stockholder Equity | -- | -- | 203.28 | 154.53 | 140.81 | 156.44 | 177.07 | 166.64 | 149.13 | 151.55 | 150.97 | 153.81 | 153.70 | 162.35 | 68.12 | 166.45 | 28.21 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Total Revenue | -- | -- | 0.00 | 0.00 | 0.00 | 2.00 | -- | -- | -- | -- | 0.00 | 0.00 | 0.67 | 0.67 | 0.68 | 0.68 | 0.67 | 0.67 | 0.68 | 0.68 |
| Cost of Revenue | -- | -- | 0.00 | 0.00 | 0.00 | 1.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 0.00 | 0.00 | 0.00 | 0.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 0.00 | 1.59 | 1.99 | 1.15 | 1.03 | 2.21 | 1.46 | 2.24 | 1.44 | 1.18 | 1.77 | 0.96 | 1.82 | 4.43 | 7.28 | 5.35 | 9.18 | 5.84 | 5.84 | 5.50 |
| Selling, General & Admin | 2.77 | 2.07 | 3.68 | 1.27 | 1.46 | 2.31 | 2.13 | 0.85 | 1.69 | 1.78 | 2.11 | 2.60 | 2.45 | -- | -- | 3.06 | 2.53 | 5.49 | 2.25 | 1.30 |
| Total Operating Expenses | -- | -- | 5.67 | 2.43 | 2.49 | 4.51 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.01 | 0.05 | 0.14 | -- | -- |
| Operating Income | (2.77) | (3.66) | (5.67) | (2.43) | (2.49) | (4.50) | (3.59) | (3.09) | (3.13) | (2.96) | (3.88) | (2.89) | (3.79) | (5.21) | (9.74) | (8.19) | (11.42) | (11.25) | (7.41) | (6.12) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.59 | 1.21 | 0.83 | -- | -- | -- | -- | -- | -- | -- | -- |
| Pretax Income | 101.59 | 49.44 | 9.80 | 59.45 | 13.13 | (7.06) | (9.78) | (18.51) | 10.84 | -- | 13.30 | (3.28) | -- | -- | -- | (7.15) | -- | -- | -- | (5.62) |
| Tax Provision | 23.43 | 11.13 | (0.21) | 11.06 | (0.13) | 0.58 | 0.42 | 1.13 | 1.63 | -- | -- | -- | -- | -- | 0.00 | 0.10 | -- | -- | -- | -- |
| Net Income | 78.16 | 38.31 | 10.01 | 48.40 | 13.29 | (7.64) | (10.23) | (19.62) | 9.21 | 1.54 | 13.34 | (3.22) | (1.19) | (3.61) | (8.74) | (7.25) | (11.07) | (10.71) | (7.60) | (5.21) |
| Basic EPS | 1.90 | 0.94 | 0.24 | 1.16 | 0.32 | (0.19) | (0.26) | (0.48) | 0.22 | 0.04 | (0.05) | 0.08 | 0.03 | 0.08 | 0.22 | 0.18 | 0.27 | 0.27 | -- | -- |
| Diluted EPS | 1.84 | 0.91 | 0.25 | 1.13 | 0.31 | (0.19) | (0.26) | (0.48) | 0.22 | 0.04 | (0.04) | 0.08 | 0.03 | 0.07 | 0.22 | 0.18 | 0.27 | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Operating Cash Flow | (0.20) | (2.91) | (0.47) | (1.62) | (3.53) | (3.52) | (1.91) | (7.10) | 2.08 | (1.48) | (1.42) | (0.69) | (2.63) | (5.55) | (8.06) | (2.24) | (8.49) | (9.12) | (6.14) | (5.64) |
| Capital Expenditures | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.20 | 0.31 | 0.12 | 0.02 | 0.05 | 0.03 | 0.00 |
| Free Cash Flow* | (0.20) | (2.92) | (0.47) | (1.62) | (3.54) | (3.52) | (1.92) | (7.11) | 2.08 | (1.48) | (1.42) | (0.73) | (2.65) | (5.75) | (8.37) | (2.36) | (8.51) | (9.17) | (6.17) | (5.64) |
| Investing Cash Flow | 4.31 | (19.49) | (1.68) | 38.36 | (54.85) | 23.62 | 15.42 | (34.26) | 94.66 | 30.00 | 30.00 | (75.12) | (14.71) | (13.20) | 11.26 | 1.23 | 10.36 | 7.36 | (29.05) | 7.39 |
| Financing Cash Flow | (1.95) | (10.36) | (4.01) | (0.36) | (0.37) | -- | (1.19) | (1.29) | (30.55) | (19.00) | (25.00) | 74.55 | 0.00 | 2.43 | 4.18 | 4.31 | -0.00 | 2.29 | 55.02 | 21.86 |
* Derived from reported values
